GILEAD SCIENCES, INC. Deferred Income Tax Assets, Net
GILEAD SCIENCES, INC. (GILD) had Deferred Income Tax Assets, Net of $2.49 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $2.49B.
- 2026-03-31: Deferred Income Tax Assets, Net $1.77B.
- 2025-12-31: Deferred Income Tax Assets, Net $1.96B.
- 2025-09-30: Deferred Income Tax Assets, Net $2.00B.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $2.49B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.77B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.96B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.00B 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.72B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.57B 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.38B 10-K · filed 2026-02-24 |
| 2017-09-30 | $1.15B 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.14B 10-Q · filed 2017-08-07 |
| 2017-03-31 | $1.21B 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.26B 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |